Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies.


Journal

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
ISSN: 1179-190X
Titre abrégé: BioDrugs
Pays: New Zealand
ID NLM: 9705305

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 22 3 2020
medline: 27 1 2021
entrez: 22 3 2020
Statut: ppublish

Résumé

Engineered red blood cells (RBCs) appear to be a promising method for therapeutic drug and protein delivery. With a number of agents in clinical trials (e.g., dexamethasone 21-phosphate in ataxia telangiectasia, asparaginase in pancreatic cancer/acute lymphoblastic leukemia, thymidine phosphorylase in mitochondrial neurogastrointestinal encephalomyopathy, RTX-134 in phenylketonuria, etc.), this leading article summarizes the ongoing efforts in developing these agents, focuses on the clinical progress, and provides a brief background into engineered RBCs and the different ways in which they can be exploited for therapeutic/diagnostic purposes. References to available data on safety, efficacy, and tolerability are reported. Due to the continuous progress in this field, the information is updated as of January 2020 from databases, websites, and press releases of the involved companies and information that is in the public domain.

Identifiants

pubmed: 32198632
doi: 10.1007/s40259-020-00415-0
pii: 10.1007/s40259-020-00415-0
pmc: PMC7211199
doi:

Substances chimiques

Drug Carriers 0
Dexamethasone 7S5I7G3JQL
Thymidine Phosphorylase EC 2.4.2.4
Asparaginase EC 3.5.1.1
Phenylalanine Ammonia-Lyase EC 4.3.1.24

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-272

Subventions

Organisme : Horizon 2020
ID : grant n. 667946

Références

J Pediatr Gastroenterol Nutr. 2006 Mar;42(3):313-5
pubmed: 16540801
Biochem Mol Biol Int. 1994 Jul;33(4):807-14
pubmed: 7981667
Front Genet. 2018 Dec 21;9:669
pubmed: 30627136
Blood Cells Mol Dis. 2004 Jul-Aug;33(1):57-63
pubmed: 15223012
Nat Commun. 2018 Jul 11;9(1):2684
pubmed: 29992966
J Inherit Metab Dis. 2016 Jul;39(4):519-30
pubmed: 27026098
Br J Haematol. 2011 Apr;153(1):58-65
pubmed: 21332712
Am J Hematol. 2015 Sep;90(9):811-8
pubmed: 26094614
Inflamm Bowel Dis. 2013 Aug;19(9):1872-9
pubmed: 23714676
Bibl Haematol. 1985;(51):7-14
pubmed: 3890828
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5):
pubmed: 28116852
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):88-103
pubmed: 26941164
Int J Pharm. 2017 Jan 30;517(1-2):175-184
pubmed: 27939571
Biotechnol Appl Biochem. 1998 Aug;28(1):1-6
pubmed: 9693082
Am J Gastroenterol. 2008 Oct;103(10):2509-16
pubmed: 18721243
Am J Gastroenterol. 2005 Jun;100(6):1370-5
pubmed: 15929772
Bioconjug Chem. 2018 Apr 18;29(4):852-860
pubmed: 29298380
Adv Exp Med Biol. 1992;326:1-15
pubmed: 1295293
Eur J Cancer. 2020 Jan;124:91-101
pubmed: 31760314
Eur J Clin Pharmacol. 1996;49(6):465-70
pubmed: 8706771
Neurology. 2008 Aug 26;71(9):686-8
pubmed: 18725595
J Clin Med. 2019 Jul 24;8(8):
pubmed: 31344955
Orphanet J Rare Dis. 2014 Jan 09;9:5
pubmed: 24405665
J Clin Med. 2019 Apr 05;8(4):
pubmed: 30959750
Eur J Clin Pharmacol. 1996;51(3-4):221-5
pubmed: 9010688
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):73-87
pubmed: 27189231
J Gen Physiol. 1958 Sep 20;42(1):9-28
pubmed: 13575771
EBioMedicine. 2018 Nov;37:366-373
pubmed: 30366815
J Pediatr Gastroenterol Nutr. 2007 Apr;44(4):423-6
pubmed: 17414137
Science. 1976 Aug 20;193(4254):681-3
pubmed: 821145
Blood Adv. 2018 Feb 13;2(3):165-176
pubmed: 29365311
Biotechnol Appl Biochem. 2001 Apr;33(2):85-9
pubmed: 11277860
Front Physiol. 2019 Aug 20;10:1070
pubmed: 31481901
Proc Natl Acad Sci U S A. 1973 Sep;70(9):2663-6
pubmed: 4354859
Bibl Haematol. 1985;(51):1-6
pubmed: 4004752
J Med Genet. 2020 Mar;57(3):145-150
pubmed: 31484718
J Pharm Pharmacol. 1990 Jul;42(7):473-6
pubmed: 1980286
Dev Neuropsychol. 2016 May-Jun;41(4):245-260
pubmed: 27805419
Mol Genet Metab. 2018 May;124(1):39-49
pubmed: 29661557
Transfus Med Rev. 2018 Apr;32(2):102-110
pubmed: 29031409
Adv Exp Med Biol. 1992;326:175-82
pubmed: 1295303
J Lab Clin Med. 1983 May;101(5):679-91
pubmed: 6187874
Neurology. 2013 Oct 1;81(14):1269-71
pubmed: 23966250
Pancreas. 2015 Oct;44(7):1141-7
pubmed: 26355551
J Control Release. 2014 Nov 28;194:37-44
pubmed: 25151978
Acta Biomater. 2020 Jan 1;101:422-435
pubmed: 31669698

Auteurs

Luigia Rossi (L)

Department of Biomolecular Sciences, Università degli Studi di Urbino Carlo Bo, 61029, Urbino, PU, Italy.
EryDel SpA, 20091, Bresso, MI, Italy.

Francesca Pierigè (F)

Department of Biomolecular Sciences, Università degli Studi di Urbino Carlo Bo, 61029, Urbino, PU, Italy.

Mattia Paolo Aliano (MP)

Department of Biomolecular Sciences, Università degli Studi di Urbino Carlo Bo, 61029, Urbino, PU, Italy.

Mauro Magnani (M)

Department of Biomolecular Sciences, Università degli Studi di Urbino Carlo Bo, 61029, Urbino, PU, Italy. mauro.magnani@uniurb.it.
EryDel SpA, 20091, Bresso, MI, Italy. mauro.magnani@uniurb.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH